source
- Amgen expands crackdown on what it says is misuse of 340B programAmgen is expanding its claims data requirements for pharmacies dispensing its drugs under the 340B federal drug discount program. The company said the new policy addresses what it claims is fraud a…Endpoints · 3mo ago↗ source
- FDA hold puts Aardvark Prader-Willi drug in limboThe company plans to unblind the late-stage study that was halted due to safety concerns, which could lead to an overhaul of its entire development program.BioPharma Dive · 3mo ago↗ source
- Supreme Court preserves access to abortion pill by mailThe ruling maintains access to the drug while litigation continues. Mifepristone can still be prescribed at pharmacies or by mail without requiring in-person visits.BioPharma Dive